文章摘要
朱 洁,周炳荣,陆 燕,郭 琴,吉 津,陈 芳,刘 佳,徐 萍.舒敏专家联合A型肉毒毒素对玫瑰痤疮患者面部症状、皮肤屏障功能及血清IL-1、IL-6和IL-37水平的影响[J].,2024,(20):3854-3856
舒敏专家联合A型肉毒毒素对玫瑰痤疮患者面部症状、皮肤屏障功能及血清IL-1、IL-6和IL-37水平的影响
Effects of Shumin Experts Combined with Botulinum Toxin Type A on Facial Symptoms, Skin Barrier Function and Serum IL-1, IL-6 and IL-37 Levels in Rosacea Patients
投稿时间:2024-05-16  修订日期:2024-06-08
DOI:10.13241/j.cnki.pmb.2024.20.011
中文关键词: 舒敏专家  A型肉毒毒素  玫瑰痤疮  面部症状  皮肤屏障功能  IL-1  IL-6  IL-37
英文关键词: Shumin expert  Botulinum toxin type A  Rosacea  Facial symptoms  Skin barrier function  IL-1  IL-6  IL-37
基金项目:国家自然科学基金项目(82073472)
作者单位E-mail
朱 洁 南京中医药大学附属医院(江苏省中医院)皮肤科 江苏 南京210029 zhujieszpfk@163.com 
周炳荣 江苏省人民医院皮肤科 江苏 南京 210029  
陆 燕 南京江宁顾泽医疗美容门诊 江苏 南京 210000  
郭 琴 南京中医药大学附属医院(江苏省中医院)皮肤科 江苏 南京210029  
吉 津 南京中医药大学附属医院(江苏省中医院)皮肤科 江苏 南京210029  
陈 芳 南京中医药大学附属医院(江苏省中医院)皮肤科 江苏 南京210029  
刘 佳 南京中医药大学附属医院(江苏省中医院)皮肤科 江苏 南京210029  
徐 萍 南京中医药大学附属医院(江苏省中医院)皮肤科 江苏 南京210029  
摘要点击次数: 32
全文下载次数: 20
中文摘要:
      摘要 目的:观察舒敏专家联合A型肉毒毒素(BTX-A)对玫瑰痤疮患者面部症状、皮肤屏障功能及血清白细胞介素-1(IL-1)、白细胞介素-6(IL-6)和白细胞介素-37(IL-37)水平的影响。方法:按照随机数字表法将120例玫瑰痤疮患者分为对照1组、对照2组、研究组,各40例。对照1组接受BTX-A治疗,对照2组接受舒敏专家治疗,研究组接受舒敏专家联合BTX-A治疗。对比三组疗效、面部症状评分、皮肤屏障功能[经皮水分丢失量(TEWL)、油脂含量、表皮含水量,皮肤pH值]及血清IL-1、IL-6和IL-37水平。结果:研究组的临床总有效率高于对照1组和对照2组(P<0.05)。研究组治疗后毛细血管扩张、红斑、皮肤潮红、丘疹脓疱评分、TEWL、皮肤pH值和血清IL-1、IL-6、IL-37水平低于对照1组和对照2组,油脂含量、表皮含水量高于对照1组和对照2组(P<0.05)。结论:舒敏专家联合BTX-A治疗玫瑰痤疮,可有效改善患者的面部症状和皮肤屏障功能,降低血清IL-1、IL-6和IL-37水平。
英文摘要:
      ABSTRACT Objective: To observe the effects of shumin experts combined with botulinum toxin type A (BTX-A) on facial symptoms, skin barrier function and serum interleukin-1 (IL-1), interleukin-6 (IL-6) and interleukin-37 (IL-37) levels in rosacea patients. Methods:120 rosacea patients were divided into control group 1, control group 2 and study group according to the random number table method, with 40 cases in each group. Control group 1 received BTX-A treatment, control group 2 received shumin expert treatment, and study group received shumin expert combined with BTX-A treatment. The efficacy, facial symptom score, skin barrier function [transcutaneous water loss (TEWL), oil content, epidermal water content, skin pH value] and serum IL-1, IL-6 and IL-37 levels were compared in three groups. Results: The total clinical effective rate in study group was higher than that in control group 1 and control group 2 (P<0.05). The scores of angiotelectasis, erythema, erubescence, papulopustule, TEWL, skin pH value and serum IL-1, IL-6 and IL-37 levels in study group were lower than those in control group 1 and control group 2 after treatment, while the oil content and epidermal water content were higher than those in control group 1 and control group 2 (P<0.05). Conclusion: Shumin experts combined with BTX-A in the treatment of rosacea, which can effectively improve the facial symptoms and skin barrier function of patients, reduce the levels of serum IL-1, IL-6 and IL-37.
查看全文   查看/发表评论  下载PDF阅读器
关闭